1:00 PM - 2:00 PM ET
10:00 AM - 11:00 AM PT
Interactive, Live webinar
This CE activity is intended for hematologist/oncologists, oncology nurses, social workers, and other healthcare professionals involved in the care of patients with chronic lymphocytic leukemia.
After completing this CE activity, the participant should be better able to:
Describe the types and subtypes of chronic lymphocytic leukemia (CLL)
Identify tests used to diagnose disease and monitor treatment
Explain approved and emerging treatment options for CLL
Describe strategies to manage treatment side effects as well as long-term and late effects of treatments
Review vaccination strategies, the impact of COVID-19, and importance of screening for secondary cancers
Describe the role of the multidisciplinary healthcare team in managing patients with CLL
William Wierda, MD, PhD
Professor of Medicine
Section Head – CLL
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX
Jill Miller, MS, PA-C
Manager, Advanced Practice Providers
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX
This activity is provided by Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society
There is no commercial support associated with this CE activity.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.